Frontlight ResearchEarly access
CompletedPhase 4
Randomized clinical trial comparing the diagnostic quality and diagnostic accuracy of pulmonary CT angiography performed with spectral CT among three iodinated contrast administration protocols, with 20, 30 and 40 mL
Key facts
- Who runs it
- Hospital General Universitario Dr. Balmis
- Where
- Spain1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 150 people enrolled
- Started
- 11 Nov 2024
- Ended
- 1 Aug 2025
- Type of study
- Interventional
- Record updated
- 16 October 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Patients referred to our department for a pulmonary CT angiography to rule out pulmonary thromboembolism
Who cannot take part
- Allergic to iodinated contrast
- Renal failure with estimated glomerular filtration rate <30 mL/min
- Patient refusal to participate in the study
- Weight less than 50 or more than 100 kg respectively
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
By measuring attenuation at pulmonary arteries, quality of perfusion maps and the diagnostic accuracy for pulmonary thromboembolism we aim to qualitatively and quantitatively compare three protocols for the administration of iodinated contrast in pulmonary CT angiography, one with 20 mL of contrast medium diluted with 20 mL of saline, another with 30 mL and another with 40 mL of iodinated contrast.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Record updated
- 16 October 2024